# Noetik says it completed first GSK oncology-AI milestone

_Tuesday, August 25, 2026 at 8:00 PM EDT · AI, Products · Latest · Tier 2 — Notable_

Noetik said it delivered and deployed inference and fine-tuning capabilities for its OCTO-VC model on August 26, meeting testing criteria in its January agreement with GSK. The milestone gives GSK a non-exclusive license to use the models for non-small cell lung cancer and colorectal cancer, according to The Tech Edvocate. The article describes the five-year collaboration as backed by $50 million in upfront capital and milestone payments.

## Sources

- [thetechedvocate.org](https://www.thetechedvocate.org/this-unseen-ai-breakthrough-just-blew-open-cancer-research/)

---
Canonical: https://techandbusiness.org/newswire/5dwd4Z2one9-6WDYuNbKV8
Retrieved: 2026-08-27T11:53:12.010Z
Publisher: Tech & Business (techandbusiness.org)